Jill A. Gershan

Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models

Susan Tsai, Laura McOlash, Katie Palen et al. · BMC Cancer · 2018 · 372 citations · Full text

STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models

Weiqing Jing, Donna McAllister, Emily P. Vonderhaar et al. · Journal for ImmunoTherapy of Cancer · 2019 · 227 citations · Full text

Sting Agonist Treatment, T-regulatory Cell, Immunology +20

Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma

Weiqing Jing, Jill A. Gershan, James J. Weber et al. · Journal for ImmunoTherapy of Cancer · 2015 · 117 citations · Full text

Astrocytes Directly Influence Tumor Cell Invasion and Metastasis In Vivo

Ling Wang, Stephanie M. Cossette, Kevin R. Rarick et al. · PLoS ONE · 2013 · 109 citations · Full text

Activate Astrocytes, Glioma, Medicine +13

Programmed Death Receptor-1/Programmed Death Receptor Ligand-1 Blockade after Transient Lymphodepletion To Treat Myeloma

Tyce Kearl, Weiqing Jing, Jill A. Gershan et al. · The Journal of Immunology · 2013 · 90 citations · Full text

Immunology, Cell Death, Plasma Cells +16